Evidence map›Paper›PMID 39958046›Full record

ArticleCureus2025

Hyperlipidemic Abdominal Crisis: A Unique Presentation of Isolated Severe Hypertriglyceridemia.

Michael Mohseni, Ayelet Elwaya, Alex Lu

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Michael MohseniEmergency Medicine, Mayo Clinic, Jacksonville, USA.
Ayelet ElwayaEmergency Medicine, Mayo Clinic, Jacksonville, USA.
Alex LuEmergency Medicine, Mayo Clinic, Jacksonville, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe hypertriglyceridemia, defined as levels >1000 mg/dL, is a condition that manifests in various ways including hyperlipidemic abdominal crisis (HLAC) with risk of progression to pancreatitis. We discuss the unique presentation of HLAC in a 50-year-old patient whose diagnosis remained unclear on initial presentation. Initial laboratory evaluation and imaging were unrevealing, but laboratory personnel relayed concerns for lipemic blood samples, prompting a lipid panel in the Emergency Department (ED). Triglycerides measured 2562 mg/dL helping to confirm probable diagnosis of HLAC. After consultation with Endocrinology, the patient was admitted for an insulin infusion with glucose-containing maintenance fluids to help treat the very severe hypertriglyceridemia. The patient was discharged in good condition on hospital day 3 with triglyceride levels down to 405 mg/dL and prescribed a new oral agent, Icosapent ethyl at 2 g orally daily. Clinicians evaluating patients for acute abdominal complaints should be alert to the possible diagnosis of HLAC given the potential for deterioration to pancreatitis and concomitant complications. Prompt management with an insulin infusion or plasmapheresis along with appropriate consultation with specialists is crucial to mitigate the risk of adverse outcomes in this rare abdominal emergency.

Indexed as

emergency medicinehyperlipidemic abdominal crisisinsulin drippancreatitisplasmapheresissevere hypertriglyceridemia

Identifiers

PMID39958046
PMCPMC11828666

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.